Sopharma Properties REIT is a special purpose investment company for securitization of real estate.
2006
1
LTM Revenue n/a
LTM EBITDA n/a
$98.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Sopharma Properties has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Sopharma Properties achieved revenue of $7.8M and an EBITDA of $8.7M.
Sopharma Properties expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Sopharma Properties valuation multiples based on analyst estimatesLTM | NTM | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | n/a | XXX | XXX | XXX | XXX |
Gross Profit | n/a | XXX | XXX | XXX | XXX |
Gross Margin | NaN% | XXX | XXX | XXX | XXX |
EBITDA | n/a | XXX | XXX | XXX | XXX |
EBITDA Margin | NaN% | XXX | XXX | XXX | XXX |
EBIT | n/a | XXX | XXX | XXX | XXX |
EBIT Margin | NaN% | XXX | XXX | XXX | XXX |
Net Profit | n/a | XXX | XXX | XXX | XXX |
Net Margin | NaN% | XXX | XXX | XXX | XXX |
Net Debt | n/a | XXX | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Sopharma Properties's stock price is BGN 8 (or $5).
Sopharma Properties has current market cap of BGN 176M (or $102M), and EV of BGN 170M (or $98.3M).
See Sopharma Properties trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$98.3M | $102M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Sopharma Properties has market cap of $102M and EV of $98.3M.
Sopharma Properties's trades at n/a EV/LTM Revenue multiple, and n/a EV/LTM EBITDA.
Equity research analysts estimate Sopharma Properties's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sopharma Properties has a P/E ratio of n/a.
See valuation multiples for Sopharma Properties and 10K+ public compsLTM | NTM | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Market cap (current) | $102M | XXX | XXX | XXX | XXX |
EV (current) | $98.3M | XXX | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | XXX | XXX | XXX |
P/E | n/a | XXX | XXX | XXX | XXX |
EV/FCF | n/a | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSopharma Properties's last 12 month revenue growth is n/a
Sopharma Properties's revenue per employee for the last 12 months averaged $7.8M, while opex per employee averaged $0.9M for the same period.
Sopharma Properties's rule of 40 is n/a (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sopharma Properties's rule of X is n/a (another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Sopharma Properties and other 10K+ public compsLTM | NTM | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue Growth | n/a | XXX | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | XXX | XXX | XXX |
Bessemer Rule of X | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $7.8M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.9M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 11% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Investcorp Capital | XXX | XXX | XXX | XXX | XXX | XXX |
Waha Capital | XXX | XXX | XXX | XXX | XXX | XXX |
ASR Nederland | XXX | XXX | XXX | XXX | XXX | XXX |
CVC Capital Partners | XXX | XXX | XXX | XXX | XXX | XXX |
Eurocommercial Props | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sopharma Properties acquired XXX companies to date.
Last acquisition by Sopharma Properties was XXXXXXXX, XXXXX XXXXX XXXXXX . Sopharma Properties acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Sopharma Properties founded? | Sopharma Properties was founded in 2006. |
Where is Sopharma Properties headquartered? | Sopharma Properties is headquartered in Bulgaria. |
How many employees does Sopharma Properties have? | As of today, Sopharma Properties has 1 employees. |
Is Sopharma Properties publicy listed? | Yes, Sopharma Properties is a public company listed on BUL. |
What is the stock symbol of Sopharma Properties? | Sopharma Properties trades under SFI ticker. |
When did Sopharma Properties go public? | Sopharma Properties went public in 2006. |
Who are competitors of Sopharma Properties? | Similar companies to Sopharma Properties include e.g. Investcorp Capital, Waha Capital, ASR Nederland, CVC Capital Partners. |
What is the current market cap of Sopharma Properties? | Sopharma Properties's current market cap is $102M |
Is Sopharma Properties profitable? | Yes, Sopharma Properties is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.